Skip to main content
TipRanks
Go Ultimate75% OFF

Advagene Biopharma Co., Ltd. (6709) Cash flow

Advagene Biopharma Co., Ltd. Cash Flow

TW:6709's free cash flow for Q2 2026 was NT$-57.96M. For the 2026 fiscal year, TW:6709's free cash flow was decreased by NT$-533.00K and operating cash flow was NT$-57.42M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -64.03MNT$ -70.64MNT$ -77.70MNT$ -109.35MNT$ -67.18M
NT$ 67.69MNT$ -89.99MNT$ 26.50MNT$ 114.29MNT$ -81.52M
NT$ -1.14MNT$ 148.26MNT$ 98.38MNT$ -1.26MNT$ 41.14M
NT$ 55.33MNT$ 52.82MNT$ 65.19MNT$ 18.01MNT$ 14.33M
NT$ -66.34MNT$ -71.12MNT$ -77.70MNT$ -119.56MNT$ -67.70M

Currency in TWD

Advagene Biopharma Co., Ltd. Cash Flow

-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing